Bio-Path Holdings, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 13.87 million compared to USD 10.44 million a year ago. Basic loss per share from continuing operations was USD 38.2 compared to USD 31 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | +2.76% | -13.57% | -75.92% |
05-15 | Transcript : Bio-Path Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
04-19 | Bio-Path Closes $1.2 Million Share Offering | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.92% | 3.4M | |
+39.66% | 54.04B | |
+43.57% | 41.96B | |
-1.18% | 41.92B | |
-7.59% | 28.35B | |
+12.76% | 26.35B | |
-22.09% | 19B | |
+7.76% | 13B | |
+28.13% | 12.28B | |
+24.66% | 12.19B |
- Stock Market
- Equities
- BPTH Stock
- News Bio-Path Holdings, Inc.
- Bio-Path Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022